Tenet Healthcare price target raised to $240 from $238 at Barclays

Barclays raised the firm's price target on Tenet Healthcare to $240 from $238 and keeps an Overweight rating on the shares. The firm adjusted targets among its U.S. healthcare facilities and managed care coverage ahead of Q2 earnings from the group.